Literature DB >> 15142294

What happens in a psychoanalysis? A view through the lens of the analytic process scales (APS).

Sherwood Waldron1, Robert D Scharf, David Hurst, Stephen K Firestein, Anna Burton.   

Abstract

A group of experienced analysts has developed scales and a coding manual illustrated with clinical examples to evaluate recorded analyses and psychodynamic therapies. The analytic process scales (APS) assesses three dimensions: (1) the contribution of the analyst: helping to develop a relationship in which the analyst can provide clarification and interpretation of transference and resistance; (2) the contribution of the patient: the communication of experience and the expression of feeling in ways which provide information about needs, wishes and conflicts, accompanied by self-reflection; and (3) interactional characteristics of the emerging relationship, explored by studying sessions divided into psychoanalytically coherent segments. A preliminary study of nine sessions has established that the variables assessed by the APS can be rated reliably. Study of the analysts' contributions illuminated their varied and complex structure. Important differences emerged among the three patient-analyst pairs studied, and changes in scores over time tracked developments in the analytic work which would imply different treatment outcomes. The APS appears to be a reliable tool facilitating the systematic study of psychoanalyses.

Entities:  

Mesh:

Year:  2004        PMID: 15142294     DOI: 10.1516/002075704773889832

Source DB:  PubMed          Journal:  Int J Psychoanal        ISSN: 0020-7578


  2 in total

Review 1.  Measuring Verbal Psychotherapeutic Techniques-A Systematic Review of Intervention Characteristics and Measures.

Authors:  Antje Gumz; Barbara Treese; Christopher Marx; Bernhard Strauss; Hanna Wendt
Journal:  Front Psychol       Date:  2015-11-10

2.  Manual for Transference Work Scale; a micro-analytical tool for therapy process analyses.

Authors:  Randi Ulberg; Svein Amlo; Per Høglend
Journal:  BMC Psychiatry       Date:  2014-11-18       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.